Find the latest pharmaceutical market place for formulations enquiry about Cysteamine Bitartrate on PharmaCompass.com.

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various Finished Dosage Formulations needed in Turkey [ENA11135]

A company that deals in oncology, urology, women's health and rare diseases and offers innovative treatments and ground-breaking genetic technologies is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with PIC/S GMP and CoA.
1. Clobazam (10 mg) Tablets
2. Cysteamine Bitartrate (50 mg & 150 mg) Tablets
3. Defibrotide (200 mg) Vials
4. Diazoxide (25 mg & 100 mg) Tablets
5. Dronedarone (400 mg) Tablets
6. Eribulin Mesylate (0.44 mg/ ml) Vials

Reply

17 Aug 2021

turkeypng-1602828403png-1622460951png-1622462103 Flag

Cystagon (50 mg & 150 mg) Capsules as RLD needed in Turkey [ENA08805]

An innovative and growth-oriented pharmaceutical Turkish company is looking for suppliers of Cystagon (50 mg & 150 mg) Capsules as RLD. The required quantity is 1 pack for each.

Reply

14 Oct 2020

Cysteamine Bitartrate (150 mg) Capsules needed in Jordan [ENA08263]

ESNA Healthcare, a consultancy firm based in the Netherlands is looking for suppliers of Cysteamine Bitartrate (150 mg) Capsules for the Middle East market. The required quantity is 15,000 units. Interested suppliers can contact them via their email: eissa.agour@esnahealthcare.nl.

Reply

17 Aug 2020